Page results
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
T16 North is a specialist adult haematology inpatient ward dedicated to providing high-quality care for patients with a wide range of blood disorders.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
UCLH Find & Treat team explain why screening is vital on World Hepatitis Day
-
This information aims to help answer some of the questions that you may have about having a robotic bilateral salpingo-oophorectomy (removal of tubes and ovaries).
-
Contrast Extravasation (contrast leakage) patient information leaflet
-
We are pleased to have performed very well again in this year's General Medical Council National Training Survey.
-
A second mass vaccination event will be held over four days this month at Emirates Stadium in a bid to give thousands more people the chance to have their first or second dose of the Pfizer Covid-19 vaccine.
-
Matthew Fielden and Lillyanne Tran volunteer in the cognitive disorders outpatients’ clinic at the National Hospital for Neurology and Neurosurgery.
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
File results
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0336 - Number of pagers currently in use at the Trust
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0337 - Trac systems e-recruitment software used at the Trust
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0330 - Outsourced/ in-house occupational health provisions